CoChat

Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53

Honda, Reiko, Tanaka, Hirofumi, Yasuda, Hideyo · 1997 · FEBS Letters

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Abstract

The tumor suppressor p53 is degraded by the ubiquitin‐proteasome system. p53 was polyubiquitinated in the presence of E1, UbcH5 as E2 and MDM2 oncoprotein. A ubiquitin molecule bound MDM2 through sulfhydroxy bond which is characteristic of ubiquitin ligase (E3)‐ubiquitin binding. The cysteine residue in the carboxyl terminus of MDM2 was essential for the activity. These data suggest that the MDM2 protein, which is induced by p53, functions as a ubiquitin ligase, E3, in human papillomavirus‐uninfected cells which do not have E6 protein.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0014-5793(97)01480-4

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 28 references

Research works printed but not linked: 2

  1. Maki C.G., 1996, Cancer Res., 56, 2649
  2. Funabiki H. Yamano H. Nagao K. Tanaka H. Yasuda H. Hunt T. and Yanagida M. (1997) EMBO J. in press.

Cited by

See all 1,951

Metadata

Authors
Honda, R., Tanaka, H., & Yasuda, H.
Affiliations
Tokyo University of Pharmacy and Life Sciences (JP)
Corresponding author
Yasuda, Hideyo
Venue
FEBS Letters
Publisher
Wiley
Published
1997-12-22
Volume
420
Issue
1
Pages
25-27
ISSN
  • 0014-5793 (ISSN-L)
  • 1873-3468
OpenAlex
W2007249806
Cited by
1,951
References
28
Citations by year
2026: 28 · 2025: 40 · 2024: 40 · 2023: 46 · 2022: 60 · 2021: 50 · 2020: 75 · 2019: 55 · 2018: 52 · 2017: 55 · 2016: 75 · 2015: 57 · 2014: 102 · 2013: 68 · 2012: 82
FWCI
22.93
Type
journal article
Language
en
Open access
closed
Locations
  • FEBS Letters (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Keywords
MDM2, p53, E3 ubiquitin ligase, ubiquitin-proteasome system, protein degradation, polyubiquitination, cysteine residues, tumor suppressor
MeSH terms
Amino Acid Sequence, Cell Extracts, HeLa Cells, Humans, Ligases, Molecular Sequence Data, Nuclear Proteins, Proto-Oncogene Proteins, Ubiquitins, Tumor Suppressor Protein p53, Sequence Analysis, Ubiquitin-Conjugating Enzymes, Proto-Oncogene Proteins c-mdm2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. https://app.cochat.ai/papers/10.1016/s0014-5793(97)01480-4
The paper
Honda, R., Tanaka, H., & Yasuda, H. (1997). Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Letters. https://doi.org/10.1016/s0014-5793(97)01480-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.